Publication Name	World Journal of Gastroenterology
Manuscript ID	12954
Country	Belgium

Received	2014-07-30 09:48
Peer-Review Started	2014-07-31 12:21
To Make the First Decision	2014-08-15 12:08
Return for Revision	2014-08-19 10:14
Revised	2014-09-05 19:16
Second Decision	2014-11-17 12:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-11-19 09:33
Articles in Press	2014-11-19 09:46
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-01-09 12:08
Publish the Manuscript Online	2015-01-20 20:12

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects
Manuscript Source	Unsolicited Manuscript
All Author List	Silvia Berardis, Prenali Dwisthi Sattwika, Mustapha Najimi and Etienne Marc Sokal
Funding Agency and Grant Number
Corresponding Author	Silvia Berardis, MD, Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires St Luc, Université Catholique de Louvain, Avenue Hippocrate 10, 1200 Brussels, Belgium. silvia.berardis@uclouvain.be
Key Words	Liver fibrosis; Cirrhosis; Mesenchymal stem cells; Cell therapy; Hepatic stellate cells
Core Tip	Liver fibrosis is a major public health issue for which no treatment is available. Cell therapy and, in particular, mesenchymal stem cells (MSCs), represent a promising strategy, based mainly on their immunomodulatory properties and differentiation capacity. In the current review, we discuss the rationale to propose cell therapy and, in particular, MSCs to treat liver fibrosis, overview of the current knowledge in this field and highlight future prospects.
Publish Date	2015-01-20 20:12
Citation	Berardis S, Dwisthi Sattwika P, Najimi M, Sokal EM. Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects. World J Gastroenterol 2015; 21(3): 742-758
URL	http://www.wjgnet.com/1007-9327/full/v21/i3/742.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i3.742

Full Article (PDF)	WJG-21-742.pdf
Full Article (Word)	WJG-21-742.doc
Manuscript File	12954-Review.docx
Answering Reviewers	12954-Answering reviewers.pdf
Copyright License Agreement	12954-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	12954-Language certificate.pdf
Peer-review Report	12954-Peer reviews.pdf
Scientific Misconduct Check	12954-CrossCheck.jpg
Scientific Editor Work List	12954-Scientific editor work list.pdf